From Premium Logistics To A True Partner In Global Life Science Supply Chain Management
Part one of Marken CEO Wes Wheeler’s ten part blog series about the changing face of Life Science Logistics in today’s fast-paced pharmaceutical industry. By Wesley Wheeler, CEO, Marken
By Wesley Wheeler, CEO, Marken
Part one of Marken CEO Wes Wheeler’s ten part blog series about the changing face of Life Science Logistics in today’s fast-paced pharmaceutical industry.
The increasing complexity of supply chain logistics due to the growing number of biologically derived drugs is impacting the cost of logistics. Some recent estimates predict that the cost of cold chain logistics will rise by 12-15% each year. Adding to this complexity, the FDA is increasing the requirements for handling these important new medicines.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Logistics Online? Subscribe today.